S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ambu A/S stock logo
AMBBY
Ambu A/S
$15.92
$16.68
$9.45
$17.48
$3.74BN/A347 shsN/A
Ansell Limited stock logo
ANSLF
Ansell
$15.05
$15.69
$13.24
$17.66
N/AN/A900 shs53 shs
Ansell Limited stock logo
ANSLY
Ansell
$63.17
$63.10
$52.59
$75.95
N/AN/A536 shsN/A
ConvaTec Group PLC stock logo
CNVVY
ConvaTec Group
$14.13
+0.4%
$13.60
$9.90
$15.40
N/AN/A8,353 shs1,939 shs
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
$225.35
-16.5%
$275.08
$175.12
$321.11
N/AN/A363 shs2 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ambu A/S stock logo
AMBBY
Ambu A/S
0.00%-5.86%-7.22%-5.59%+11.01%
Ansell Limited stock logo
ANSLF
Ansell
0.00%0.00%-1.21%-7.67%-25.12%
Ansell Limited stock logo
ANSLY
Ansell
0.00%0.00%0.00%+2.67%-14.46%
ConvaTec Group PLC stock logo
CNVVY
ConvaTec Group
+0.36%-1.50%-4.56%+14.65%+32.63%
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
-16.54%-18.05%-21.23%-6.88%-27.19%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ambu A/S stock logo
AMBBY
Ambu A/S
N/AN/AN/AN/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
N/AN/AN/AN/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLY
Ansell
N/AN/AN/AN/AN/AN/AN/AN/A
ConvaTec Group PLC stock logo
CNVVY
ConvaTec Group
N/AN/AN/AN/AN/AN/AN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
0.0566 of 5 stars
0.00.00.80.01.90.01.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ambu A/S stock logo
AMBBY
Ambu A/S
3.00
BuyN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
N/AN/AN/AN/A
Ansell Limited stock logo
ANSLY
Ansell
N/AN/AN/AN/A
ConvaTec Group PLC stock logo
CNVVY
ConvaTec Group
2.80
Moderate BuyN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
2.50
Moderate BuyN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ambu A/S stock logo
AMBBY
Ambu A/S
N/AN/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
N/AN/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLY
Ansell
N/AN/AN/AN/AN/AN/A
ConvaTec Group PLC stock logo
CNVVY
ConvaTec Group
N/AN/AN/AN/AN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ambu A/S stock logo
AMBBY
Ambu A/S
N/AN/A0.00N/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
N/A$0.3148.72N/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLY
Ansell
N/A$1.2451.12N/AN/AN/AN/AN/A
ConvaTec Group PLC stock logo
CNVVY
ConvaTec Group
N/AN/A0.00N/AN/AN/AN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
N/A$4.3152.29N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ambu A/S stock logo
AMBBY
Ambu A/S
N/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
$0.402.68%N/A130.40%N/A
Ansell Limited stock logo
ANSLY
Ansell
$0.701.11%N/A56.91%N/A
ConvaTec Group PLC stock logo
CNVVY
ConvaTec Group
$0.281.98%N/AN/AN/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
$1.200.53%N/A27.84%N/A

Latest SDMHF, AMBBY, ANSLF, ANSLY, and CNVVY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/26/2024
ConvaTec Group PLC stock logo
CNVVY
ConvaTec Group
$0.14324/25/20244/26/20246/7/2024
2/22/2024
Ansell Limited stock logo
ANSLY
Ansell
$0.613/1/20243/4/20243/28/2024
(Data available from 1/1/2013 forward)

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Ambu A/S stock logo
AMBBY
Ambu A/S
N/A
Ansell Limited stock logo
ANSLF
Ansell
38.97%
Ansell Limited stock logo
ANSLY
Ansell
0.60%
ConvaTec Group PLC stock logo
CNVVY
ConvaTec Group
N/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
9.21%

Insider Ownership

CompanyInsider Ownership
Ambu A/S stock logo
AMBBY
Ambu A/S
N/A
Ansell Limited stock logo
ANSLF
Ansell
N/A
Ansell Limited stock logo
ANSLY
Ansell
N/A
ConvaTec Group PLC stock logo
CNVVY
ConvaTec Group
N/A
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Ambu A/S stock logo
AMBBY
Ambu A/S
4,400234.97 millionN/ANot Optionable
Ansell Limited stock logo
ANSLF
Ansell
14,000N/AN/ANot Optionable
Ansell Limited stock logo
ANSLY
Ansell
14,000N/AN/ANot Optionable
ConvaTec Group PLC stock logo
CNVVY
ConvaTec Group
10,136N/AN/ANot Optionable
Sartorius Stedim Biotech S.A. stock logo
SDMHF
Sartorius Stedim Biotech
10,662N/AN/ANot Optionable

SDMHF, AMBBY, ANSLF, ANSLY, and CNVVY Headlines

SourceHeadline
Sartorius Stedim Biotech gets grant for multiparameter lateral flow membrane for testing multiple analytesSartorius Stedim Biotech gets grant for multiparameter lateral flow membrane for testing multiple analytes
pharmaceutical-technology.com - April 17 at 9:14 AM
Sartorius Stedim Biotech is about to announce its earnings — heres what Wall Street expectsSartorius Stedim Biotech is about to announce its earnings — here's what Wall Street expects
markets.businessinsider.com - April 17 at 9:14 AM
Sartorius Stedim Biotech (OTCMKTS:SDMHF)  Shares Down 1.8% Sartorius Stedim Biotech (OTCMKTS:SDMHF) Shares Down 1.8%
americanbankingnews.com - April 16 at 1:48 AM
Sartorius Stedim Biotech SA ADR SRTOYSartorius Stedim Biotech SA ADR SRTOY
morningstar.com - February 28 at 11:20 PM
Sartorius Stedim Biotech S.A. (SDMHF)Sartorius Stedim Biotech S.A. (SDMHF)
finance.yahoo.com - February 20 at 12:15 AM
Sartorius Stedim Biotech Shares Fall After Capital IncreaseSartorius Stedim Biotech Shares Fall After Capital Increase
marketwatch.com - February 7 at 4:34 AM
Sartorius Stedim Biotech Completes $1.3 Bln Capital IncreaseSartorius Stedim Biotech Completes $1.3 Bln Capital Increase
marketwatch.com - February 7 at 4:34 AM
Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlookSartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook
markets.businessinsider.com - January 26 at 2:29 AM
SARTORIUS (SARTF) Q3 Earnings Lag EstimatesSARTORIUS (SARTF) Q3 Earnings Lag Estimates
finance.yahoo.com - October 19 at 9:08 AM
Sartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim BiotechSartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim Biotech
markets.businessinsider.com - July 21 at 8:26 AM
Sartorius Stedim Biotech H1 Profit, Orders Down; Backs Weak FY23 OutlookSartorius Stedim Biotech H1 Profit, Orders Down; Backs Weak FY23 Outlook
markets.businessinsider.com - July 21 at 8:26 AM
Sartorius Stedim Biotech Q1 Profit Declines, Sales Revenue Down 18.4% Organically; Confirms OutlookSartorius Stedim Biotech Q1 Profit Declines, Sales Revenue Down 18.4% Organically; Confirms Outlook
markets.businessinsider.com - April 20 at 8:57 AM
Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 1.44 euros per share to the Annual Shareholders’ MeetingBoard of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 1.44 euros per share to the Annual Shareholders’ Meeting
boersennews.de - February 8 at 1:53 PM
Sartorius Stedim Biotech FY22 Profit Rises, Orders Down; Sees Growth In FY23; Raises FY25 Sales ViewSartorius Stedim Biotech FY22 Profit Rises, Orders Down; Sees Growth In FY23; Raises FY25 Sales View
markets.businessinsider.com - January 26 at 7:16 AM
Preliminary results 2022 of Sartorius Stedim BiotechPreliminary results 2022 of Sartorius Stedim Biotech
technews.tmcnet.com - January 26 at 2:15 AM
Nine-month results 2022 of Sartorius Stedim BiotechNine-month results 2022 of Sartorius Stedim Biotech
finance.yahoo.com - October 19 at 1:59 AM
Sartorius Stedim Biotech H1 Profit Climbs; Confirms FY22 Outlook - Quick FactsSartorius Stedim Biotech H1 Profit Climbs; Confirms FY22 Outlook - Quick Facts
markets.businessinsider.com - July 21 at 2:00 AM
Sartorius Stedim Earnings Miss, Revenue Beats In Q1Sartorius Stedim Earnings Miss, Revenue Beats In Q1
investing.com - April 21 at 7:39 AM
Sartorius Stedim Biotech S.A. Non-GAAP EPS of €2.21, revenue of €862.5MSartorius Stedim Biotech S.A. Non-GAAP EPS of €2.21, revenue of €862.5M
seekingalpha.com - April 21 at 2:05 AM
Sartorius Stedim acquires Novaseps chromatography division; boosts sales guidanceSartorius Stedim acquires Novasep's chromatography division; boosts sales guidance
seekingalpha.com - February 8 at 4:41 AM
Sartorius Stedim Biotech Non-GAAP EPS of €7.46, revenue of €2.89BSartorius Stedim Biotech Non-GAAP EPS of €7.46, revenue of €2.89B
seekingalpha.com - January 28 at 11:44 PM
Single-use Bioreactors Market worth $8.8 billion by 2026 – Major Players are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US)Single-use Bioreactors Market worth $8.8 billion by 2026 – Major Players are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US)
benzinga.com - November 17 at 11:13 PM
Looking for a Growth Stock? 3 Reasons Why SARTORIUS (SARTF) is a Solid ChoiceLooking for a Growth Stock? 3 Reasons Why SARTORIUS (SARTF) is a Solid Choice
finance.yahoo.com - November 16 at 2:44 PM
Sartorius Stedim Earnings, Revenue beat in Q3Sartorius Stedim Earnings, Revenue beat in Q3
au.investing.com - October 20 at 7:22 AM

Media Sentiment Over Time

Company Descriptions

Ambu A/S logo

Ambu A/S

OTCMKTS:AMBBY
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides anaesthesia, and patient monitoring and diagnostics products. The company offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
Ansell logo

Ansell

OTCMKTS:ANSLF
Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.
Ansell logo

Ansell

OTCMKTS:ANSLY
Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.
ConvaTec Group logo

ConvaTec Group

OTCMKTS:CNVVY
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Sartorius Stedim Biotech logo

Sartorius Stedim Biotech

OTCMKTS:SDMHF
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.